- Welcome the Delaware Chapter of the American College of Cardiology
- Welcome the Delaware Chapter of the American College of Cardiology
Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- GEIST Registry Characterizes “Happy Heart†Form of Takotsubo SyndromeHappy heart syndrome is a rare type of takotsubo syndrome (TTS) and has a higher prevalence of male patients and atypical, nonapical ballooning, compared with the more commonly known broken heart syndrome that is associated with negative emotional stressors, according to a study published June 27 in JACC: Heart Failure.
- Cardiovascular Disease Risk Among Cancer SurvivorsWhat is the risk of cardiovascular disease (CVD) in cancer survivors?
- A Randomized Controlled Trial with Resolute Onyx in One Month DAPT for High-Bleeding Risk PatientsThe goal of the Onyx ONE trial was to compare the safety and efficacy of 1 month of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) with either the Resolute Onyx drug-eluting stent (DES) or with the BioFreedom drug-coated stent (DCS) among patients at high bleeding risk.
- Ethnicity-Dependent Performance of the GRACE Risk ScoreWhat is the performance of the GRACE (Global Registry of Acute Coronary Events) score in a racially diverse non–ST-segment elevation myocardial infarction (NSTEMI) population, particularly its ability to predict all-cause in-hospital mortality in different racial groups of patients?
- Objective Randomized Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable AnginaThe goal of the ORBITA trial was to assess the efficacy of percutaneous coronary intervention (PCI) compared with a sham placebo procedure for angina relief among patients with stable angina.